Scoliosis
in
fi
Thalassemia
Skeletal abnormalities in patients with homozy-gous 3 thalassemia have been noted as early as 1927 by Cooley et al’ and have been the subject of many
reviews.25
Abnormalities have been observed in the entire skeletal system, especially the skull and themandible, giving the patients a characteristic ap-pearance. Bone changes cause mainly expansion of the medullary cavity, subperiosteal overgrowth of the bones of the skull, and cortical thinning with porous rarefaction ofthe long bones. Although most
of
the bone abnormalities in inadequatelytrans-fused thalassemic patients result from the over-growth of the bone marrow, hypoparathyroidism
and vitamin C deficiency occasionally occur and
may cause bone deformities.6’7 Recently, skeletal abnormalities and growth retardation in fi thalas-semic patients have been associated with early
mi-tiation
of
iron-chelation therapy and the resulting zinc depletion.8This study reports the spine abnormalities in 3 thalassemia identified by clinical and radiological evaluation of randomly selected patients.
MATERIALS AND METHODS
We studied 67 thalassemic patients, 34 males and
33 females, treated during the past 7 years in the Thalassemia Unit of the University of Patras
Med-ical School at the Regional General University Hos-pital of Patras. The patients were randomly
Se-lected among the 120 patients followed up in the Thalassemia Unit, with the only criterion being their willingness to participate in the study. Eleven (16.4%) of the 67 patients had f thalassemia inter-media, whereas the remainder 56 (83.6%) had f thalassemia major. Eight (11.9%) ofthe 67 patients,
aged 9 years or older, had had splenectomy per-formed at an earlier age.
The mean chronological age ± SD of the patients
studied was 10.4 ± 3.8 years, with a range from 3
to
20 years. Only two patients were older than 16 years.All patients were transfused with 10 to 15 mL of
washed red blood cells per kilogram of body weight,
at intervals of 15 to 30 days depending on the
hematocrit value. Over the 7-year follow-up period
the mean hematocrit ± SD was 34.5 ± 2.3%. All
Received for publication Mar 23, 1990; accepted Sep 21, 1990 Reprint requests to (N.G.B.) Dept of Pediatrics, University of Patras Medical School, P0 Box 1045, 261 10 Patras, Greece. PEDIATRICS (ISSN 0031 4005). Copyright © 1991 by the American Academy of Pediatrics.
patients except six, who refused the treatment, were treated with subcutaneous infusions of defer-oxamine. The mean deferoxamine dose ± SD they
reported receiving was 49.2 ± 18.2 mg/kg per day,
4 to 5 days per week. The recommended daily dose
was
40 to 60 mg/kg per day, 5 days per week. Themean
age ± SD of the 61 patients at the initiation of the deferoxamine treatment was 5.0 ± 2.2 years. Themean
duration ± SD of the deferoxamine therapy was 5.3 ± 3.0 years. Plasma ferritin levelwas
measured every 6 months. The mean ferritin value ± SD was 2914 ± 1684 ng/mL.In all /3 thalassemic patients studied a physical
examination was performed, with particular
atten-tion
paid to signs of scoliosis and other spinal deformities. Sexual maturity was determined ac-cording to Tanner.9 Each patient had a roentgeno-gram of the left hand performed for skeletal age determination.’0 Also, all patients had a standing posteroanterior roentgenogram of the spine fores-timation
of
the location (thoracic, thoracolumbar,lumbar, or S-shaped), direction (right or left), ro-tation of the apical vertebra (rotation of the pedicle of the apical vertebra in relation to the position of
the lateral side ofthe vertebral body), and extention
of
the scoliosis curvature (number of vertebrae in-cluded in the scoliotic curvature). The degree of the rotation of the apical vertebra was determined ac-cording to the method of Nash and Moe.” The grading 0 to IV is made by the location of the pedicle shadow on the convex side of the scolioticcurvature.
In grade 0 rotation the pedicle shadows are equidistant from the sides of the vertebral body.In grade IV, that is the most severe degree of
vertebral rotation, the pedicle shadow is past the
center of the vertebral body. A lateral standing roentgenogram of the spine was also obtained for determining the sagittal profile of the spine.
Studies were performed with the informed
con-sent of the patients and in the case of children,
with the informed consent of their parents.
Regression analysis, the r coefficient, the x2 test,
and the t test were used for the statistical analysis
of
the data.RESULTS
Of the 67 thalassemic patients studied, 44 (65.7%) were found to have a scoliosis of 5#{176}Cobb
or more. Thirteen (29.5%) of the 44 scoliotic pa-tients had a scoliosis of 10#{176}Cobb or more, whereas
the remaining 31 patients (70.5%) had a curvature
between 5#{176}and 9#{176}Cobb. The greatest curvature observed was 15#{176}Cobb. Figure 1 illustrates the distribution of the patients with scoliosis according
to the degree of the major curvature. Table 1 lists
the rotation
of
the apical vertebra of the majorcurvature
according to Nash and Moe.” Sixty-onepercent of the patients with scoliosis had a left-sided curvature, whereas in 43.2% of them the pattern of the curve was left lumbar. The difference
between left- and right-sided scoliosis was statisti-cally significant (t = 2.36, P < .025). Also, the
difference between left- and right-sided lumbar
sco-liosis was statistically significant (t = 2.55, P <
.01). However, no statistically significant difference was found between left- and right-sided scoliosis located at the thoracic (t = 0.382, P > .25) and the
thoracolumbar region (t = 0.89, P > .1), but the
number of such patients was too small for
mean-ingful analysis. The greatest lumbar, thoracic, and S-shaped curvatures observed were 12#{176},15#{176},and
14#{176},respectively. It must be noted that of the 67 thalassemic patients studied, 6 (8.9%) had a
ky-phosis of 7#{176}to 24#{176}located at the thoracolumbar region of the spine.
Twenty patients with scoliosis were males,
whereas the remaining 24 were females. The ratio of females to males was 1.24:1.0. The difference in the frequency of scoliosis between males and
fe-males was not statistically significant (x2 = 0.861,
P.3).
Also, there was no significant difference in the occurrence of scoliosis between patients with the
20
6” z
If, 12
I-. z w
4
0
5-7 7-9 9-11 11-13 1315 15 Ii
;IADtS OF 5C01 ItJ;i;
Fig 1. Distribution of the scoliotic patients according to
the degree of the major curvature.
major or the intermedia form of 3 thalassemia. Of the 56 patients with the major form of the disease,
35 (62.5%) had scoliosis, whereas of the 11 patients with the intermedia form, 9 (81.8%) had scoliosis
(x2 1.522, P .2).
All eight patients who had previously undergone
splenectomy had scoliosis. The difference in the occurrence of scoliosis between patients with and
without splenectomy was statistically significant
(x2 4.749, P .05). Splenectomized and
nonsple-nectomized patients had a similar mean hematocrit
value (34.3 ± 1.3 and 34.6 ± 2.4%, respectively; t =
0.298, P > .375), deferoxamine dose (50.4 ± 3.6 and
49.0 ± 19.1 mg/kg per day, respectively; t = 0.197,
P > .4), and plasma ferritin value (3538 ± 2127 and 2828 ± 1617 ng/mL, respectively; t = 1,12, P > .1). In four patients with splenectomy and scoliosis the
curvature pattern was left lumbar, in two right
lumbar, and in two S-shaped.
The standing roentgenograms of the spine dem-onstrated certain widespread structural bone
ab-normalities, such as osteopenia, cortical thinning
of vertebral body, and increased vertebral trabecu-lation. Osteopenia was the commonest abnormality, observed on the vertebrae of 62 patients (92.5%).
In 47 patients (70.1%) there was marked cortical
thinning of the vertebral body, and in 25 (37.3%) there was increased trabeculation of the spine. In
25 patients (37.3%), all vertebral abnormalities
de-scribed above were present. However, there was no correlation between these structural vertebral bone abnormalities and scoliosis, inasmuch as scoliosis appeared with the same frequency both in patients
with
one or more of the previously described ver-tebral abnormalities and in patients without any abnormal roentgenographic findings.Some patients with scoliosis showed localized structural deformities of the fourth and less
fre-quently of the fifth lumbar vertebral body. Of the 44 patients with scoliosis, 4 (9.1%) had flattening ofthe fourth lumbar vertebral body and 5 additional patients (11.4%) had a wedge deformation also of
the fourth vertebral body demonstrated by the pos-teroanterior roentgenogram. In these patients the
TABLE 1. Location and Direction of the Scoliotic Curvature (Convexity) and Grades of
Rotation of the Apical Vertebra of the Major Curvature According to Nash and Moe” in fi Thalassemic Patients With Scoliosis*
Location of Sco- Direction Grade of Rotation
liosis
Right Left Total 0 1 2 3
Thoracic 3 4 7 . . . 7 ...
Lumbar 8 19 27 . .. 20 7 ...
Thoracolumbar 2 4 6 .. . 4 2 ...
Total 13 27 40 .. . 31 9 ...
* Total
x2
= 1.017, P > .90._,15
S
13
0
S
C 11
U
07>SSS
U, 55555
9 S
w
(.5 5 - 55
5 .*.a*.. , .R* ,*. ,S
2 6 10 14 18
A6E (YEARS)
Fig 2. Correlation between the age of the scoliotic
pa-tients and the degree of the major curvature; r = .467, P
.001.
degree and the side of the wedge deformation of the L-4 corresponded well with the degree and the side
of
scoliosis. The youngest of the above patients was4 years old. In 1 patient a first-degree spondylolis-thesis of the L-5 was detected and in another there
was spondylolysis of the L-5. A lateral rotational
sliding of the L-4 was observed in a patient with a left-sided scoliosis (L-1-L-5) of 10#{176},with a rotation
of
the apical vertebra estimated to be grade II according to Moe.No correlation was observed between scoliosis
and the existence
of some
potential etiological fac-tors, such as low or high ferritin levels, adequate orinadequate blood transfusions, and high or low doses of deferoxamine. Specifically, of the 6
pa-tients who were never treated with deferoxamine, 4
had scoliosis, whereas of the 61 who received iron
chelation therapy, 40 had scoliosis. Statistical analysis of the data demonstrated no difference
between the two groups of patients
(x2
0.003,
P> .95).
Table 2 demonstrates the distribution of the
chronological and the skeletal age of the
thalas-semic patients with and without scoliosis. The
youngest patient with scoliosis was 3.5 years old.
In the group of 2- to 7-year-olds, all three patients
aged 5 years and eight of the nine patients aged 6 years had scoliosis. All these patients had
main-tamed
a
good hematocrit value up to the time ofthe study because they had been cared for from early life in our Thalassemia Unit. Furthermore, there was no statistically significant difference in the occurrence of scoliosis between different age
groups (total x2 = 3.132, P .3), indicating that
the frequency of scoliosis did not increase with age.
Bone maturation was retarded in most
of
the pa-tients and, therefore, scoliosis appeared not only invery young patients, but in young patients who also
had a retarded skeletal age. The mean skeletal age
± SD of the thalassemic patients was 9.1 ± 3.7 years, with a range from 2 to 17 years. The mean
retardation, therefore, of the skeletal age ± SD was 1.2 ± 1.2 years. Table 3 lists the number of patients
with and without scoliosis according to the stage of
sexual maturation by Tanner.9 The frequency of scoliosis was similar in all five stages of maturation.
Although the frequency of scoliosis did not in-crease with advancing age, the magnitude of the
curvatures
was
greater in the older patients than in the younger ones. Figure 2 illustrates the correla-tion between the age of the scoliotic patients andthe degree of the major curvature (r = .467, P
.01). Up to the age of 10 years there were 19 patients with a curve from 5#{176}to 9#{176}Cobb and only 3 patients with a scoliosis curve of 10#{176}Cobb or more. On the contrary, in the patients older than 10 years, 10 had a scoliosis curve of 10#{176}Cobb or more and only 12 had a curve of 9#{176}Cobb or less. The difference in
TABLE 3. Stage
Tanner9 and Pres
assemic Patients*
of enc
Sexual Maturation According to
e or Absence of Scoliosis in
Thal-Stage of Maturation
Patients With Thalasse-mia
No. (%) No. (%)
Without With
Scoliosis Scoliosis
I
II
III IV V
14 (32.6) 29 (67.4)
4 (50.0) 4 (50.0)
3 (30.0) 7 (70.0) 1 (33.3) 2 (66.7)
1 (33.3) 2 (66.7)
TABLE 2. Scoliosis in j3 Thalassemic Patients According to Chronological and Bone
Age*
Age Groups, y
Chronol ogical Age Bone Age
No. of Patients
No. (%) With
Sco-liosis
No. of Patients
No. (%) With
Sco-liosis
2-7 16 12 (75.0) 18 14 (77.8)
7-12 25 17 (68.0) 32 19 (59.4)
12-17 24 13 (54.2) 15 9 (60.0)
17-22 2 2 (100.0) 2 2 (100.0)
* Presence vs absence of scoliosis (chronological age): total x2 = 3.132, P > .3. Presence
v.1
U,
0
-S
0 U
U,
La. 0
0
4
CD
15
‘3
11
9
7
c
S
S S
55 S_
S S S#{149}SS S#{149} #{149}
0 2000 4000 6000
1[RRITIN (ng/ml)
Fig 3. Correlation between the ferritin levels of the scoliotic patients and the degree of the major curvature;
r = .375, P .05.
the magnitude of scoliosis between patients older and younger than 10 years was statistically signifi-cant (x2 5.35, P .05).
Patients with scoliosis and high ferritin levels in
the plasma developed curves of greater magnitude than patients with low ferritin levels (Fig 3). The
difference was significant (r = .375, P s .05). No
relationship was identified between the magnitude
of
scoliosis and the presence or absence of chronic anemia or the dose of deferoxamine given. Also, there was no significant difference in the prevalenceof
scoliosis between patients with early and lateinitiation
of
the iron-chelation therapy.DISCUSSION
Differences in the prevalence of idiopathic
sco-liosis in the general population have been reported
by various investigators. Shands and Eisberg’2 noted idiopathic scoliosis of 10#{176}or more in 1.9% of individuals older than 14 years, with a female-male
ratio
of
3.5:1.0. Patynski et al’3 studied children 7 to 15 years old and found scoliosis in approximately2.6% of them, whereas Bruszewski and Kamza’4 reported a prevalence of scoliosis in the general population of 3.7%. Wynne-Davies,’5 in a survey of 10 000 schoolchildren in Edinburgh, noted scoliosis
in
1.3 per 1000 younger than the age of 8 and in 1.8per 1000 older than the age of8. In children younger
than 8 years, the ratio of female to male was 1:1,
but in children older than the age of 8 this ratio was 23:1. The incidence of idiopathic scoliosis
greater than 5#{176}in Athens, Greece, among children aged 10 to 15 years was found to range between
3.7%
and 7 7% 16The severity of scoliosis depends on the degree
of
the scoliotic curvature. Curvatures 5#{176}to 30#{176}are characterized as mild, 30#{176}to 60#{176}as moderate, and greater than 60#{176}as severe. In this study, 44 (65.7%)S of the 67 /3 thalassemic patients investigated had a
scoliosis curve between 5#{176}and 15#{176}.In idiopathic
scoliosis the progression of the disorder depends on the location and direction of the scoliotic curvature and the rotation
of
the apical vertebra. The most severe forms of the disease are right thoracic witha rotation grade III to IV. In the /3 thalassemic patients we investigated, the left lumbar curvatures were the most frequent. Also, the greatest rotation observed was grade II. Although the natural history
8000 of scoliosis in thalassemia is not well determined
at the present time, it appears that it is different from that of the idiopathic. It is of interest that scoliosis in 3 thalassemia appears very early in
childhood, between the third and the seventh year
oflife. The fact that its prevalence does not increase
with age after the seventh year suggests that no
new cases appear after this age. Although the prey-alence of the disorder does not enhance with age, there is a significant increase in the magnitude of
the scoliosis curves in older patients, indicating that
the spinal deformity is slowly progressing. The association between high plasma ferritin levels and greater degrees of scoliosis suggests that iron
ac-cumulation is an important factor leading to the
progression of scoliosis. In only a small number of
patients wedge deformation of the L-4 had led to lumbar scoliosis.
In all ages, male and female thalassemic patients
were approximately equally affected. However, only
a limited number of patients older than 16 years were investigated and the bone maturation in the
majority of the patients was retarded. Evaluation,
therefore, of older thalassemic patients and
long-term follow-up of young patients is warranted,
in-asmuch as the current treatment protocol has in-creased the life expectancy of these patients and it
is expected that they will survive even longer.
Although bone abnormalities in thalassemia
have been described since 1927’ and many subse-quent papers have been published on this
sub-ject,25”7 scoliosis in
fi
thalassemia has never been described earlier. The question, therefore, hasarisen
whether scoliosis is a manifestation of 3thalassemia per se or whether it is a complication resulting from the application of the modern
treat-ment
regimens.
Indeed, in a recent paper DeVir-gillis et a18 reported that initiation of iron-chelation
therapy as early as the first year of life results in
significant bone deformities and short stature, pos-sibly due to zinc depletion by the deferoxamine
treatment. However, in all patients included in the
study, the deferoxamine treatment was begun after
the second or third year of life. Furthermore, there was no correlation between the prevalence of
pa-REFERENCES
1. Cooley TB, Witwer ER, Lee P. Anemia in children with
splenomegaly and peculiar changes in the bones. AJDC. 1927;34:347-363
2. Aksoy M, Camli N, Dincol K, Erdem 5, Dincol G. On the problem of ‘rib-within-a-rib’ appearance in thalassemia in-termedia. Radiol Gun BiOL 1973;42:126-133
3. Caffey I. Cooley’s anemia: a review of the roentgenographic findings in skeleton. Am J RoentgenoL 1975;78:381-391 4. Middlemis JH, Raper AB. Skeletal changes in the
haemo-gbobinopathies. J Bone Joint Surg Br. 1966;48B:693-702 5. Moseley JE. Skeletal changes in the anemias. Semin
Roent-genoL 1974;9:169-184
6. Flynn DM, Fairney A, Jackson D, Clayton BE. Hormonal changes in thalassemia major. Arch Dis Child. 1976;51:828-836
7. Gabrielle 0. Hypoparathyroidism associated with
thalasse-mia. South Med J. 1971;64:115-116
8. De Virgillis ST, Congia M, Frau F, et al. Deferoxamine induced growth retardation in patients with thalassemia major. J Pediatr. 1988;113:661-669
9. Tanner JM. Growth atAdolescence. 2nd ed. Oxford, England: Blackwell Scientific Publications; 1962
10. Greulich WW, Pyle SI. Radiographic Atlas of Skeletal
De-velopment of the Hand and Wrist. 2nd ed. Stanford, CA:
Stanford University Press; 1959
11. Nash C, Moe J. A study of vertebral rotation. J Bone Joint Surg Am. 1969;51A:223
12. Shands AR Jr, Eisberg HB. The incidence of scoliosis in the state of Delaware: a study of 50 000 minifilms of the chest made during a survey for tuberculosis. J Bone Joint Surg Am. 1955;37A:1243-1249
13. Patynski J, Szczekot J, Szwaluk F. Boczne skrzywienie Kregoslupa w swietle statystyki. Chir Narzadow Ruchu Or-top PoL 1957;22:111-114
14. Bruszewski J, Kamza Z. Czestosc wystepowania skolioz na podstawieanalizy zdec maloobrazkowych. Chir Narzadow
Ruchu Ortop PoL 1957;22:115-116
15. Wynne-Davies R. Infantile idiopathic scoliosis. J Bone Joint Surg Br. 1975;57B:138-141
16. Smyrnis P, Valavanis J, Alexopoulos A, Siderakis G, Gi-anestras NJ. School screening for scoliosis in Athens. J
Bone Joint Surg Br. 1979;61B:215-217
17. Dines DM, Canale VC, Arnold WD. Fractures in thalasse-mia. J Bone Joint Surg Am. 1976;58A:662-666
18. Weatherall DJ, Clegg JB. The Thalassaemia Syndromes. 3rd
ed. Oxford, England: Blackwell Scientific Publications tients with low or high ferritin values, and finally
patients receiving high or low doses of
deferoxam-me.
These findings suggest that the treatmentreg-imens applied may not be responsible for the initial development of scoliosis. However, it is noteworthy that a positive correlation was identified between
high ferritin levels and the degree of the scoliosis
curvatures.
It appears that whichever are thepath-ogenetic mechanisms that lead to the development
of scoliosis, they operate early during the first few years
of
life.It should be noted that scoliosis developed in all
splenectomized patients. This observation may in-dicate that splenectomy can be a factor contributing
to
the appearance of scoliosis. Statistical analysisfailed to demonstrate an association of scoliosis in
the splenectomized patients with the mean
hema-tocrit
value, the deferoxamine dose, and the plasmaferritin levels.
The intermedia form of the disease differs from the
major
form
in
that the hemolytic process ismilder and, therefore, patients are subjected less
frequently to blood transfusions.’8 However,
sco-liosis appeared with a similar frequency in patients
with both forms of the disease.
In conclusion, it was found that scoliosis of 5#{176}
Cobb or more developed in more than half of the patients with fi thalassemia. Inasmuch as the degree of scoliosis increased with age, the skeletal
matu-ration was delayed, and the life span of the
thalas-semic patients is steadily increasing, it is necessary
to
observe these patients for long periods of timeto determine the magnitude of the scoliosis process and treat the patients, if it becomes necessary. In addition, long-term follow-up studies may help to
uncover
the pathogenetic mechanism(s) causing scoliosis in 3 thalassemic patients.OURANIA PAPAGEORGIOU, MD DIMITRIS A. PAPANASTASIOU, MD
NICHOLAS G. BERATIS, MD Dept
of
PediatricsUniversity of Patras Medical School
Regional General University Hospital
Patras, Greece
PANAGIOTIS KOROVESSIS, MD Dept of Orthopedics
General Hospital “St Andreas”
Patras
ALEKOS OIK0NOM0P0UL0S, MD
Dept of Radiology
1991;88;341
Pediatrics
BERATIS, PANAGIOTIS KOROVESSIS and ALEKOS OIKONOMOPOULOS
OURANIA PAPAGEORGIOU, DIMITRIS A. PAPANASTASIOU, NICHOLAS G.
Thalassemia
β
Scoliosis in
Services
Updated Information &
http://pediatrics.aappublications.org/content/88/2/341
including high resolution figures, can be found at:
Permissions & Licensing
http://www.aappublications.org/site/misc/Permissions.xhtml
entirety can be found online at:
Information about reproducing this article in parts (figures, tables) or in its
Reprints
http://www.aappublications.org/site/misc/reprints.xhtml
1991;88;341
Pediatrics
BERATIS, PANAGIOTIS KOROVESSIS and ALEKOS OIKONOMOPOULOS
OURANIA PAPAGEORGIOU, DIMITRIS A. PAPANASTASIOU, NICHOLAS G.
Thalassemia
β
Scoliosis in
http://pediatrics.aappublications.org/content/88/2/341
the World Wide Web at:
The online version of this article, along with updated information and services, is located on
American Academy of Pediatrics. All rights reserved. Print ISSN: 1073-0397.